Eversana, Cryoport partner on regenerative medicine supply chain

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/metamorworks)
(Image: Getty/metamorworks)

Related tags: Cryoport, Logistics, Eversana, Biologics

Eversana adopts Cryoport’s full suite of logistics services, in an alliance expected to ‘drive synergistic growth’ for both companies and answer regenerative medicine demands.

Biopharmaceutical logistics services provider Cryoport announced a strategic alliance under which Eversana will gain access to its full offering of logistics solutions’.

Specifically, the alliance will see Eversana adopt Cryoport’s express shippers, Cryoportal logistics management platform, SmartPak II condition monitoring system, and logistics management.

The partners expect this alliance to enable an effective supply chain solution for therapeutic advancements of Eversana’s clients and support the development of regenerative medicines, including CAR T-cell and gene therapies.

Jim Lang, CEO of Eversana said in a statement:“The promise of regenerative medicine requires an innovative look at the complete product life cycle from market access planning through efficient distribution and best-in-class patient support.”

"[Cryoport’s] temperature-controlled logistics solutions are currently used by almost all of the leading biopharma companies,”​ Lang noted, adding that the alliance will drive revenue growth for both companies and provide value to clients.

Jerrell Shelton, CEO of Cryoport, said Eversana is ‘building a powerhouse,’ serving over 500 life sciences companies in over 100 therapeutics areas, and commented that this partnership answers the demand for temperature-controlled supply chain services.

According to Shelton, “The regenerative therapy market is in its infancy with support requirements evolving and this alliance is designed to capture the vast opportunities at the "head of the stream.”

Related news

Show more

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us

Products

View more

Webinars